Cytokeratin 20 and vascular endothelial growth factor as molecular markers in Egyptian patients with colorectal cancer

Abstract

Purpose. To investigate the expression of cytokeratin 20 (CK20) and vascular endothelial growth factor (VEGF) in the peripheral blood of colorectal cancer (CRC) patients, and correlate the findings with the pathologic data of the patients.

Methods. This study was carried out on 50 subjects, 40 patients with histologically confirmed colorectal carcinoma undergoing elective surgery and 10 healthy individuals matched for age and sex. Total RNA extraction followed by real time quantitative RT-PCR and real time TaqMan quantitative assay for peripheral blood expression of CK20 and VEGF was done for both patients and controls.

Results. (1) Statistically significant high levels of CK20,VEGF, CEA (p = 0.000 each) and CA19-9 (p = 0.002) in CRC patients when compared with controls; (2) Statistically significant increase in the expression of CK20 in advancing CRC stage C (p = 0.001) and with LN metastasis (p = 0.000); (3) Statistically significant increase in the expression of VEGF in advancing CRC stage C (p = 0.002), pathologic grade (p = 0.038), and with LN metastasis (p = 0.004); and (4) statistically positive correlation between CK20 and VEGF expressions, and also between these markers and CEA level. Conclusion. CK20 and VEGF expressions in peripheral blood of CRC patients are promising molecular markers for CRC progression and metastasis.

Keywords

colorectal carcinoma CK20 VEGF CEA CA-19.9 real-time PCR

Get full access to this article

View all access options for this article.

References

Saha D. , Roman C. , and Beauchamp RD New strategies for colorectal cancer prevention and treatment. World J Surg 2002; 26(7): 762-766.

Okuno K. Surgical treatment for digestive cancer. Current issues - colon cancer. Dig Surg 2007; 24(2): 108-114.

Buyse M. , Piedbois P. Should Dukes’ B patients receive adjuvant therapy? A statistical perspective . Semin Oncol 2001; 28(Suppl 1): 20-24.

Wang JY , Wu CH , Lu CY , Hsieh JS , Wu DC , Huang SY , et al. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J Surg 2006; 30(6): 1007-1013.

Chu PG , Wu E. , and Weiss LM Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol 2000; 13(9): 962-972.

Lee JC , Chow NH , Wang ST , and Huang SM Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 2000; 36(6): 748-753.

Dukes C. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323-332.

Lugo TG , Braun S. , Cote RJ , Pantel K. , and Rusch V. Detection and measurement of occult disease for the prognosis of solid tumors . J Clin Oncol 2003; 21(13): 2609-2615.

Duffy MJ , Van Dalen A. , Haglund C. , et al. Clinical utility of biochemical markers in colorectal cancer: European group on tumor markers (EGTM) guidelines. Eur J Cancer 2003; 39(6): 718-727.

10.

Khafagy W. , El-Ghazaly M. , and El-Shobaky M. Colorectal cancer in Egypt. Does it differ? Coloproctology 2000; 22: 109.

11.

Choi SW , Lee KJ , Bae YA , Min KO , Kwon MS , Kim KM , et al. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res 2002; 8(7): 2311-2322.

12.

Gryfe R. , Kim H. , Hsieh ET , Aronson MD , Holowaty EJ , Bull SB , et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342(2): 69-77.

13.

Boyle P. and Leon ME Epidemiology of colorectal cancer. Br Med Bull 2002; 64: 1-25.

14.

Jover R. , Zapater P. , Castells A. , Llor X. , Andreu M. , Cubiella J. , et al. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006; 55(6): 848-855.

15.

Aljebreen AM Clinico-pathological patterns of colorectal cancer in Saudi Arabia: Younger with an advanced stage presentation. Saudi J Gastroenterol 2007; 13(2): 84-87.

16.

Weitz J. , Koch M. , Debus J. , Höhler T. , Galle PR , and Büchler MW Colorectal cancer. Lancet 2005; 365(9454): 153-165.

17.

Fenoglio-Preiser CM , Noffsinger AE , Stemmermann GN , et al. Carcinoma and other epithelial and neuroendocrine tumor of the large intestine. In: Fenoglio-preiser CM (ed.) Gastrointestinal pathology, An atlas and text, Chapter 20, Philadelphia: Lippincott-Raven, 1999.

18.

Abou-Zeid AA , Khafagy W. , Marzouk DM , Alaa A. , Mostafa I. , and Ela MA Colorectal cancer in Egypt. Dis Colon Rectum 2002; 45(9): 1255-1260.

19.

Duffy MJ Carcinoembryonic antigen as a marker for colorectal cancer: Is it clinically useful? Clin Chem 2001; 47(4): 624-630.

20.

Grotowski M. , Maruszyński M. , and Piechota W. Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients. Pol Merkur Lekarski 2001; 11(66): 476-479.

21.

Wang JY , Lu CY , Chu KS , Ma CJ , Wu DC , Tsai HL , et al. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res 2007; 39(4): 245-250.

22.

Wang WS , Lin JK , Chiou TJ , Liu JH , Fan FS , Yen CC , et al. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroenterology 2002; 49(43): 160-164.

23.

Chelly J. , Concordet JP , Kaplan JC , et al. Illegitimate transcription: Transcription of any gene in any cell type. Proc Natl Acad Sci USA 1989; 86(8): 2617-2621.

24.

Jung R. , Petersen K. , Kruger W. , Wolf M. , Wagener C. , Zander A. , et al. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 1999; 81(5): 870-873.

25.

Chausovsky G. , Luchansky M. , Figer A. , Shapira J. , Gottfried M. , Novis B. , et al. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung. Cancer 1999; 86(11): 2398-2405.

26.

Weitz J. , Kienle P. , Magener A. , Koch M. , Schrödel A. , Willeke F. , et al. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 1999 ; 5(7): 1830-1836.

27.

Friederichs J. , Gertler R. , Rosenberg R. , Nahrig J. , Führer K. , Holzmann B. , et al. Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma . World J Surg 2005; 29(4): 422-428.

28.

Xu D. , Li XF , Zheng S. , and Jiang WZ Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients. J Zhejiang Univ Sci B 2006; 7(6): 445-451.

29.

Soeth E. , Roeder C. , Juhl H. , Kruger U. , Kremer B. , and Kalthoff H. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996; 69(4): 278-282.

30.

Wyld DK , Selby P. , Perren TJ , Jonas SK , Allen-Mersh TG , Wheeldon J. , et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 1998; 79(3): 288-293.

31.

Na GW , Li J. , He KJ , Li HH , Zhao XN , Li XW , et al. CK20 mRNA expression in peripheral blood of patients with gastrointestinal carcinoma and its clinical significance. Ai Zheng 2004; 23(11): 1350-1353.

32.

Knösel T. , Emde V. , Schlüns K. , Schlag PM , Dietel M. , and Petersen I. Cytokeratin profiles identify diagnostic signatures in colorectal cancer using multiplex analysis of tissue microarrays. Cell Oncol 2006; 28(4): 167-175.

33.

Friederichs J. , Gertler R. , Rosenberg R. , Dahm M. , Nekarda H. , Holzmann B. , et al. Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma. World J Surg 2007; 31(12): 2329-2334.

34.

Galizia G. , Lieto E. , Ferraraccio F. , Orditura M. , De Vita F. , Castellano P. , et al. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 2004; 10(10): 3490-3499.

35.

Nakasaki T. , Wada H. , Shigemori C. , Miki C. , Gabazza EC , Nobori T. , et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer . Am J Hematol 2002; 69(4): 247-254.

36.

Mysliwiec P. , Piotrowski Z. , Zalewski B. , Kukliński A. , and Pawlak K. Plasma VEGF-A and its soluble receptor R1 correlate with the clinical stage of colorectal cancer . Rocz Akad Med Bialymst 2004; 49(Suppl 1): 85-87.

37.

Celen O. , Kahraman I. , Yildirim E. , and Berberoglu U. Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients. Neoplasma 2004; 51(4): 293-299.

38.

Ferroni P. , Palmirotta R. , Spila A. , Martini F. , Formica V. , Portarena I. , et al. Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer. Oncology 2006; 71(3-4): 176-184.

39.

Fujisaki K. , Mitsujama K. , Toyonaga A. , Matsuo K. , and Tanikawa K. Circulating vascular endothelial growth factor in patients with colorectal cancer. Am J Gastroenterol 1998; 93(2): 249-252.